Clinical Trials Browser

OTHER × Positron-Emission Tomography × Breast × Clear all

NCT06586047 2026-03-27

Breast Cancer PSMA PET

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00367666 2026-03-10

Using Diagnostic Tools to Stage Breast Cancer

Phase NA Active not recruiting

Breast Neoplasms

NCT05376878 2026-02-23

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Phase 4 Recruiting

Brain Neoplasms, Breast Neoplasms

NCT02810873 2025-05-04

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

Phase NA Terminated

19 enrolled 7 charts

Breast Neoplasms

NCT05632601 2024-11-04

HER-CROWN

Phase NA Recruiting

BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

NCT01931709 2023-11-18

FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer

Phase NA Terminated

35 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT03057743 2021-11-18

Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer

Breast Neoplasms

NCT02708511 2018-04-05

Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer

Phase 1 Terminated

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT02437539 2015-08-24

uPAR-PET

Phase 1 Completed

BreastGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Prostatic Neoplasms